Loic Lang-Lazdunski

Title: Loic Lang-Lazdunski: Innovator in Spinal Cord Injury Prevention

Introduction

Loic Lang-Lazdunski is a notable inventor based in Neuilly, France. He has made significant contributions to the field of medical science, particularly in the prevention of ischemic spinal cord injury. His innovative approach has the potential to improve patient outcomes during surgical procedures involving aortic cross-clamping.

Latest Patents

Lang-Lazdunski holds a patent for a method aimed at preventing ischemic spinal cord injury caused by aortic cross-clamping. The patent describes a method for reducing glutamate neurotoxicity, which is critical in the pathophysiology of spinal cord injury. The reduction is achieved through the administration of riluzole to patients, effectively mitigating the neurotoxic effects during and after aortic cross-clamping. This method is also applicable for reducing spinal cord injury resulting from ischemia and for lessening the effects of ischemia on neuronal tissues. He has 1 patent to his name.

Career Highlights

Lang-Lazdunski is affiliated with the Centre National de la Recherche Scientifique, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to transform surgical practices and enhance patient safety.

Collaborations

Throughout his career, Lang-Lazdunski has collaborated with esteemed colleagues, including Michel Lazdunski and Catherine Louise Heurteaux. These partnerships have fostered a collaborative environment that promotes innovative research and development in the medical field.

Conclusion

Loic Lang-Lazdunski's contributions to the prevention of ischemic spinal cord injury highlight his role as a significant inventor in medical science. His innovative methods and collaborations continue to pave the way for advancements in patient care and surgical techniques.